(Q35987352)

11 August 2017

Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil (English)

1 reference

11 August 2017

arterial hypertension

1 reference

D Dunbar Ivy

1

1 reference

11 August 2017

Lori Claussen

series ordinal

2

1 reference

11 August 2017

Aimee Doran

series ordinal

3

1 reference

11 August 2017

language of work or name

English

0 references

publication date

10 January 2007

1 reference

American Journal of Cardiology

11 August 2017

1 reference

11 August 2017

99

1 reference

11 August 2017

5

1 reference

11 August 2017

696-698

1 reference

Prostanoid therapy for pulmonary arterial hypertension.

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974790

Diagnosis and differential assessment of pulmonary arterial hypertension

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974790

Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974790

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974790

Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974790

Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974790

Pharmacokinetics and steady-state bioequivalence of treprostinil sodium (Remodulin) administered by the intravenous and subcutaneous route to normal volunteers

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974790

Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974790

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974790

Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974790

10.1016/J.AMJCARD.2006.09.119

24 September 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

1 reference